TY  - JOUR

T1  - Biochemical control with dose reduction in chronic glucocorticoid therapy over 4 years: A phase III extension study of Chronocort (Efmody) in the treatment of Congenital Adrenal Hyperplasia (CAH)

JO  - Endocrine Abstracts

UR  - http://dx.doi.org/10.1530/endoabs.99.rc3.1

PY  - 2024/05/06

AU  - John MRR

AU  - Merke DP

AU  - Arlt W

AU  - De LPAB

AU  - Hirschberg A

AU  - Newell-Price JDC

AU  - Prete A

AU  - Rees A

AU  - Reisch N

AU  - Quinkler M

AU  - Touraine PA et al

ED  - 

DO  - DOI: 10.1530/endoabs.99.rc3.1

PB  - Bioscientifica

Y2  - 2024/12/22

ER  -